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DOI: http://dx.doi.org/10.1016/j.hemonc.2015.02.001Cancer is the second leading cause of death in Jordan after cardiovascular diseases. Due to increase in
life expectancy and prolonged exposure to risk factors, cancer mortality and morbidity are expected to
increase as the young population ages. This increase will constitute a challenging burden on healthcare
systems in Jordan and many other neighboring countries. Planning is key to managing the expected rise in
the demand for cancer care, and this will require public health initiatives to guarantee access to quality
cancer care.
Over the past decade, cancer care in Jordan has witnessed remarkable improvement through access to
advanced diagnostics and therapeutics. In this review, we address the history of cancer care in Jordan,
including cancer statistics, infrastructure, workforce as well as cancer care outcomes. We also discuss
many of the challenges that we face and offer suggestions for the improvement of cancer management
in Jordan and the region.
KEYWORDS: Cancer care; Jordan; Middle EastJORDAN AS A COUNTRYJordan is an Arab country located in southwestAsia. It occupies an area of 89,000 km2 withan estimated population of 6.5 million1 and a
population growth rate of 2.2%.2 In 2011, 12.7% of
the population were under ﬁve years of age; 37.2%
were under 15 years; and only 3.3% of the total
population were above 65 years of age (Figure 1).
Jordan is divided administratively into central,
north, and south regions in which 82.6% of the
population is urban with almost two thirds residing
in the central region. Only 10% of the population live
south of the capital, Amman.2
According to the World Bank classiﬁcation,
Jordan is an upper middle-income country.3 The
Kingdom suffers from insufﬁcient supplies of water,
oil and other natural resources, poverty, unemploy-
ment, and inﬂation. In 2011, gross domestic
product (GDP) was estimated at $28.84 billion
with annual growth of about 2.6%. The country’s
budget deﬁcit has been increasing in recent years,
and the cash surplus/deﬁcit (% of GDP) was6.8 in 2011. Gross national income (GNI) per
capita is $4,380.3PUBLIC HEALTH PERSPECTIVE
Jordan’s health performance is among the better
Arab states in terms of life expectancy, infant and child
mortality rates, as well as maternal mortality rates.
Table 1 summarizes the basic public health
indicators.4
Despite an epidemiological shift towards non-com-
municable diseases, infectious diseases remain the
major causes of morbidity, including diarrhea diseases,
acute respiratory infections, and hepatitis.5 Vaccination
coverage for most infectious diseases exceeds 95%, and
the Ministry of Health (MOH) recommends vaccinat-
ing all health workers with three doses of hepatitis B
vaccine. Furthermore, Jordan is considered among
low prevalence countries for HIV/AIDS, with an
estimated prevalence of less than 0.1%.5
Non-communicable diseases (NCD) are the lead-
ing cause of death. The latest mortality report issued
by MOH for 2009 indicates that more than one thirdarter 2015
Figure 1. Population of Jordan.
Table 1. Basic public health indicators for Jordan (2011).
Indicator 2011
Population 624,900
Life expectancy at birth (years): male/female 72/74
Crude death rate (per 1000 population) 7
Infant mortality (per 1000 live births) 23
Maternal mortality (per 100,000 live births) 19
MOH budget as (%) of total government budget 6.3
MOH: Ministry of Health.
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14.6% to cancer.4 Smoking, especially among the
young, physical inactivity, obesity, and unhealthy diets
are considered serious public health problems in
Jordan, as reported in the Jordan Behavioral Risk
Factor Surveillance Survey of 2007.6,7CANCER AS PUBLIC HEALTH PROBLEM
Cancer is the second leading cause of death in
Jordan after cardiovascular diseases.5 Cancer mortality
and morbidity are expected to increase as the young
population ages with longer life expectancy. The
latter is coupled with prolonged exposure to risk
factors such as tobacco use, the consumption of
unhealthy food, sparse physical activity, as well as
exposure to environmental, industrial, and agricultural
carcinogens.
In Jordan, the government bears the cost of treat-
ing cancer patients. Cancer treatment is offered at no
cost to all Jordanian citizens through public hospitalsHematol Oncol Stem Cell Ther 8(2) Second Quarter 2015including the MOH, Royal Medical Services (mili-
tary), university hospitals and King Hussein Cancer
Center (KHCC). Recently, King Hussein Cancer
Center and King Hussein Cancer Foundation
(KHCF) took the lead in changing the insurance
landscape for cancer patients, introducing a nonproﬁt
cancer insurance program that partially covers the cost
of cancer care at KHCC for program participants
who pay affordable premiums. The major private
insurance companies do not cover cancer screening
or treatment.
Cancer care in Jordan is focused on treatment,
with less effort being placed on other elements of
the cancer continuum. Despite several initiatives,
Jordan does not have a national cancer control plan
as of 2014. In countries where cancer control pro-
grams have been implemented, the burden of cancer
is decreasing and treatment outcomes are improving,
supporting the need for Jordan to pursue this strategic
goal.8 Organized cancer control, as promoted by inter-
national organizations such as the World Health
Organization (WHO), its Eastern Mediterranean
Regional Ofﬁce (EMRO) and the Union for
International Cancer Control (UICC), offers the
best approach for healthcare systems to be more
integrated, cost-effective, and efﬁcient in preventing
cancer. For cancer patients, it enhances cure rates,
relieves pain, and improves quality of life.CANCER ETIOLOGY
The high prevalence of smoking is associated with
high incidence of lung cancer, which is the leading cause
of cancer death in Jordan. Besides lung cancer, tobacco
use also increases the risk of cancers of the head and
neck, colon, bladder, and acute leukemia; all are among
the most common neoplasms in Jordan. Viral-65
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associated cancers have low prevalence in Jordan. Only
41 cases of cervical cancer were registered in 2010,
representing 1.6% of all female cancers.9 Cancer of
the liver and biliary passages are not common, with
113 (2.3%) cases registered in 2010.9 Worldwide,
cancer-causing viral infections such as HBV/HCV
and HPV are responsible for up to 20% of cancer
deaths in low and middle-income countries.10
There is no published work on the incidence of
inherited familial cancer syndromes, like hereditary
breast and ovarian cancer syndrome (HBOC) that is
associated with mutations in BRCA1 and BRCA2, or
familial adenomatous polyposis in colon cancer.
However, work is ongoing to study the prevalence of
BRCA1 and BRCA2 mutation in high risk breast cancer
patients (H. Abdel-Razeq, MD. Chief Medical Ofﬁcer,
King Hussein Cancer Center, Date: Jan 01, 2015,
Hikmat N. Abdel-Razeq, M.D. Chief Medical Ofﬁcer,
Deputy Director General, personal communication).CANCER STATISTICS
National cancer registration began in 1996 with the
establishment of the Jordan Cancer Registry (JCR) as a
population-based registry under the jurisdiction of the
MOH, which publishes an annual incidence report.
The number of new cancer cases diagnosed among
Jordanians has increased 44% in the past decade, from
3362 cases in 2000 to 4849 in 2010 (Figure 2). The
male to female ratio was 0.92:1 and the overall median
age at diagnosis was 56 (60 years for males and 52 years
for females).9 The crude incidence rate of all cancers
among Jordanians was 79.4 per 100,000 (74 for males
and 85.1 for females). The Age Standardized Incidence
Rate (ASR) adjusted to the world standard population
was 135.1 per 100,000, which represents an increase by
8.5% from the ASR in 2000 (124.5 per 100,000 pop-
ulation). Nevertheless, Jordan’s ASR for cancer is simi-
lar to other Arab countries in the region and much
lower than the ASR in Europe and North America.
The top ﬁve cancers among Jordanian males and
females are detailed in Figure 2. This ranking has not
signiﬁcantly changed in the past ten years.9
Data on mortality due to cancer shows that lung
cancer is the most common cause of death in males,
accounting for 30.2% followed by colorectal (10.3%)
and prostate cancers (6.2%). In females, breast cancer
is the most common (22.4%) followed by colorectal
(8.9%), and lung (7.0%). However, it should be noted
that the last rapid assessment of Jordan’s civil registra-
tion and vital statistics system by WHO echoed con-
cerns about the accuracy of cause of death data
reported by JCR.11HISTORY OF CANCER CARE
During the nineties, cancer care in Jordan was deliv-
ered in a fragmented approach, with lack of coordina-
tion in the plan of care between pathologists,
radiologists, surgeons, and clinical oncologists.
Patients were insured by the government and were
referred, upon diagnosis with cancer, to public and pri-
vate hospitals in or even outside Jordan. There was sev-
ere deﬁciency in patient support services such as
palliative care, nutrition, psychosocial support and
rehabilitation.
In 1997, the King Hussein Cancer Foundation and
Center (KHCF/KHCC) were established as stand-
alone independent non-governmental, not-for-proﬁt
institutions founded by royal decree to combat cancer
in Jordan and the region. The foundation signed a
cooperative agreement with the National Cancer
Institute of the United States (National Institutes of
Health) and began a journey to transform the hospital
into a comprehensive cancer center for cancer care,
training and education as well as research.12
Following intense efforts, KHCC gained accred-
itation by Joint Commission International (JCI) in
2006, and accreditation as an oncology center
equipped to treat all types of adult and pediatric can-
cers followed in 2008. Currently, KHCC treats
around 60% of cancer cases in Jordan, in addition
to treatment of patients from neighboring countries.CANCER CARE INFRASTRUCTURE AND
WORKFORCE
The major cancer treatment modalities (surgery,
radiation, chemotherapy) are generally available, and
most services are concentrated in the capital Amman,
except for King Abdullah University Hospital in the
north. KHCC is the only specialized tertiary hospital
that provides all treatment modalities and services for
cancer care, in addition to a bone marrow trans-
plantation unit for both adults and pediatrics.
Most of the institutions offer multiple diagnostic
and clinical specialties. However, across these institu-
tions, variable gaps exist with regard to the availability
or sufﬁciency of equipment and staff in certain disci-
plines. Psychological and palliative care services are
signiﬁcantly scarce. In the absence of certain medical
services within an institution, referral to other institu-
tions is common and can help address certain gaps.
However, such referrals have implications with regard
to interruption of patient care, and furthermore may
inﬂuence patient load and waiting times in the institu-
tion providing supplemental care. The effect of suchHematol Oncol Stem Cell Ther 8(2) Second Quarter 2015
Figure 2. Cancer incidence.
CANCER CARE IN JORDAN special research reportdiscontinuity of care and/or overload on the outcome
of care has not been analyzed.
Jordan hosts an adequate number of specialized
medical, surgical, and radiation oncologists who have
been trained in medical schools in the Kingdom and
abroad. In addition, advanced diagnostic methods
are available through pathologists and radiologists in
addition to adult and pediatric critical care specialists,
which collectively enhance the ability to diagnose and
treat complex cases of cancer.
On the other hand, there is a shortage of nurses,
especially females, who are trained to meet the com-
plex needs of cancer patients, and there are few spe-
cialized ancillary support personnel who can deliver
advanced support services to enhance quality of life
as well as treatment outcomes.CANCER CLINICAL CARE
Cancer care in Jordan is advanced in comparison to
most neighboring countries, and the country hosts
many local and western-trained physicians who can
deliver various cancer treatment modalities.
Nevertheless, coordinated multidisciplinary manage-
ment of cancer patients is weak, and can be seen as rou-
tine practice only at KHCC through multidisciplinary
organized teams (MDT) or clinics (MDC). Many of
these MDTs or MDCs routinely discuss their cases
through telemedicine with colleagues at rebuttableHematol Oncol Stem Cell Ther 8(2) Second Quarter 2015cancer centers like M.D. Anderson Cancer Center,
St. Jude’s Children Research Hospital in the USA,
and Hospital for Sick Children in Canada.13CANCER CARE OUTCOMES
Data on cancer care outcomes are not available at a
national level. However, the recent introduction of a
hospital-based cancer registry and research unit at
KHCC has made treatment outcomes for all cancer
types available to clinicians, researchers, and policy
makers. Examples of the ﬁve-year survival data for
patients treated at KHCC are shown in Figure 3.
Despite concerns among treating physicians regarding
limited access to new targeted chemotherapeutics and
the increasing use of generics, survival data are
comparable to those observed in more developed
countries. This further validates the ability of health-
care systems with limited resources to combat cancer.CANCER CARE CONTINUUM
Prevention
Cancer prevention is an essential component of the
ﬁght against cancer. Over one third of all cancers can
be prevented through the control of known risk fac-
tors.14 Unfortunately, many cost-effective and
inexpensive prevention measures have yet to be widely
implemented in many countries, including Jordan.67
Figure 3. Cancer survival.
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are eligible for primary prevention, namely: lung, col-
orectal, urinary bladder, and stomach cancers.9
Lung cancer is the most preventable form of cancer
death in Jordan. Tobacco use remains a major public
health problem; both cigarette smoking and the use of
water pipes, called shishas or nargileh, are common,
even among Jordanian youth. The 2009 WHO
Global Tobacco Youth Survey reported a smoking
rate of 11.5% among youth (13–15 years old).15 A
recent cross-sectional study in a convenient sample
of adults 18 years or older showed that an average
of 71% of males and 21% of females reported use of
cigarettes in the past 30 days.16 Passive smoking is
also a major issue with up to 80% of people being
exposed to second-hand smoke.17
Jordan signed the Framework Convention on
Tobacco Control (FCTC) and swiftly ratiﬁed it in
2004. Public Health Law No. 47/2008 prohibits
the sale of tobacco products to minors (under the
age of 18) and provides the legislative framework for
100% smoke-free public places, public transport and
healthcare facilities. The smoking ban, however, isnot yet adequately enforced as it lacks effective
mechanisms for implementation and for the adequate
training of responsible staff. Smoking cessation clinics
are currently available at MOH and KHCC, provid-
ing counseling and antismoking drugs. Moreover,
KHCC is an active partner in the Global Bridges, a
healthcare alliance for tobacco dependence treatment
in collaboration with Mayo Clinic.18
Jordanians are moving towards a western lifestyle
with increased consumption of processed food and
decreased levels of physical activity; an estimated
30% of the population are overweight and 35%
obese. The National Youth Strategy for Jordan pro-
motes recreation and encourages youth to become
more physically active and lead healthier lifestyles,
but implementation and impact are yet to be
determined.19
Larger population-based surveys on detailed
elements of knowledge, attitudes, and practices asso-
ciated with cancer are needed to better understand
how preventive efforts can be successful. Similarly,
the level of knowledge in cancer prevention and early
detection among ﬁrst line health workers needs to beHematol Oncol Stem Cell Ther 8(2) Second Quarter 2015
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ascertained, so that they may become effective and
active partners in cancer prevention.
Screening
In a population where the majority of the cancers
amenable to early detection are diagnosed in late
stages, the establishment of an early detection pro-
gram may be the most feasible strategy. The Jordan
Breast Cancer Program (JBCP) is a national program
established in 2005 that includes major stakeholders.
JBCP aims to downstage the current state of breast
cancer diagnosis from its late stages (III and IV) to
its earlier stages (0, I and II) where the disease is most
curable, survival rates are highest, and treatment costs
are lowest. Recently, KHCC and JBCP introduced a
mobile mammography unit with centralized reading
at KHCC to aid in increasing access of patients to
breast cancer screening.
To help unify and standardize the diagnostic
approach for breast cancer, JBCP developed breast
cancer screening and diagnosis guidelines (based on
the National Comprehensive Control Network guide-
lines), which were published in 2008.20 However, the
feasibility of developing and sustaining a national
screening program in a resource-constrained setting
such as Jordan remains questionable.
Psychosocial care
This area is underdeveloped in Jordan and, with
the exception of KHCC, most cancer care facilities
in the Kingdom lack structured programs for psy-
chosocial support. The Psychosocial Oncology
Program at KHCC provides emotional and spiritual
support to improve quality of life for patients and
families and to facilitate the best possible outcome
of the treatment process. Social workers, alongside
healthcare management teams, interact with and
address the emotional and social needs of patients
and their families to facilitate patient access to treat-
ment and their compliance with treatment.
Palliative care
Palliative care is an emerging specialty in Jordan,
and faces many challenges. It is estimated that more
than 20% of newly diagnosed cancer patients present
to healthcare systems in advanced stages, and most of
these patients are incurable at presentation, making
palliative care the only option to relieve their suffer-
ing. In 2001, the Jordan Palliative Care Initiative
was established, aiming to promote and develop
national palliative care in Jordan. In 2004, the pallia-
tive care program at KHCC was established as the
ﬁrst comprehensive service in the country, in whichHematol Oncol Stem Cell Ther 8(2) Second Quarter 2015an interdisciplinary team provides care at multiple set-
tings, including outpatient, inpatient, and home
care.21
In a recent review of palliative care development
levels around the globe, Jordan was classiﬁed within
the category of ‘‘generalized provision of palliative
care’’.22 This group of countries is characterized by
the development of palliative care activism in several
locations, multiple sources of funding, the availability
of morphine, several hospice-palliative care services
from a community of providers who are independent
of the healthcare system, and the provision of some
training and education initiatives by hospice organiza-
tions. However, many barriers continue to hamper
the development and availability of palliative care in
the country, including negative professional and pub-
lic attitudes towards palliative care, lack of specialized
human resources, in addition to interrupted opioids
supply and availability.CANCER RESEARCH
Despite the advanced care delivered to cancer
patients in Jordan, such care is not integrated with
clinical research. Publications emphasizing bench-to-
bedside or bedside-to-bench applications are rarely
encountered. In many of our local institutions, physi-
cians are not required to conduct research, and recog-
nition at the national and regional level is not tied to
the ‘‘publish or perish’’ rule widely known elsewhere.
In addition, residency and fellowship programs are
mainly dependent on clinical care and continuing
medical education hours with weak emphasis on
research methodologies. In 2011–2012, Jordanian
researchers published a total of 105 original articles
that were mainly retrospective reviews of patient data
in addition to a few basic research projects. The gov-
ernment does not have generous funds to support
research, and the ability of physicians to compete
for international research grants is limited due to
inexperience and frail collaborative networks among
individuals and institutions.
Understanding the peculiarities of cancer develop-
ment and treatment in the era of personalized medi-
cine will require commitment and coordinated effort
among all stakeholders to promote and facilitate
research.FUTURE DIRECTIONS
With approximately 14 million new cases and 8.2
million cancer-related deaths in 2012, cancer contin-
ues to be among the leading causes of morbidity69
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and mortality worldwide. The number of new cases is
expected to rise by about 70% over the next two
decades.10 Cancer cases in Jordan are also expected
to increase, reaching levels that will challenge public
and private healthcare systems and that may hinder
access of patients to life-saving treatment. The cost
of the many recently introduced targeted cancer drugs
and sophisticated radiation therapy and surgical tech-
niques will create signiﬁcant challenges for the current
insurance system. This should alert policymakers into
planning strategies and discussing alternatives.
Stakeholders should collaborate in planning for the
era of personalized cancer care, which requires
upgrading local laboratory capabilities, funding access
to targeted therapies and molecular diagnostics as well
as to patient-centered research.
Shortage in cancer care providers will be a chal-
lenge at all levels as Jordan experiences signiﬁcant
difﬁculties in attracting and retaining highly special-
ized Jordanian graduates. Financial compensationand political uncertainty in neighboring countries
and the region add to the problem. Current struc-
tured training programs for physicians, nursing and
other highly needed paramedical specialties can be
strengthened through partnerships with medical and
nursing schools, both in the Kingdom and abroad.
Last but not least, the healthcare system in Jordan
must progress towards integrated clinical care and
clinical research including research on quality, access,
and treatment outcomes with emphasis on survivor-
ship programs.CONFLICT OF INTEREST
There is no conﬂict of interest to declare.
Acknowledgments
The authors would like to thank Dr. Omar Shamieh who
provided valuable information and data on the palliative
care section.REFERENCES1. The world factbook. Jordan, Washington, DC:
Central Intelligence Agency; 2012 accessed Jan 15,
2015.
2. Statistical yearbook (Jordan). Amman:
Department of Statistics; 2011.
3. The World Bank country classification.
Washington, DC: The World Bank; 2011.
4. Ministry of health annual statistical book.
Amman. Hashemite Kingdom of Jordan: Ministry
of Health; 2011.
5. Mortality data in Jordan 2009. Amman: Ministry
of Health; <http://www.moh.gov.jo>; 2012.
6. Zindah M, Belbeisi A, Walke H, Mokdad AH.
Obesity and diabetes in Jordan: findings from the
Behavioral Risk Factor Surveillance System, 2004.
Prev Chronic Dis 2008;5:A17.
7. Al-Nsour M, Zindah M, Belbeisi A, Hadaddin R,
Brown DW, Walke H. Prevalence of selected chronic,
noncommunicable disease risk factors in Jordan:
results of the 2007 Jordan Behavioral Risk Factor
Surveillance Survey. Prev Chronic Dis 2012;9:E25.
8. National cancer control programmes: policies and
managerial guidelines. 2nd ed. Geneva: World
Health Organization; 2002.
9. Jordan Cancer Registry. Cancer Incidence in
Jordan. Amman: Ministry of Health, Jordan; 2010,
<http://www.moh.gov.jo/AR/Documents> accessed
July 01, 2014.10. Cancer Factsheet no. 297. World Health
Organization. <http://www.who.int/mediacentre/
factsheets/fs297/en/>; 2015 accessed Jan 15, 2015.
11. World Health Organization. Civil registration
and vital statistics systems in the region. Geneva;
12 March 2013, <http://www.who.int/healthinfo/
global_burden_disease/LifeTablesMethods_1990_
2011.pdf> accessed July 01, 2014.
12. Moe JL, Pappas G, Murray A. Transformational
leadership, transnational culture and political com-
petence in globalizing health care services: a case
study of Jordan's King Hussein Cancer Center.
Global Health 2007;3:11.
13. Qaddoumi I, Mansour A, Musharbash A, Drake
J, Swaidan M, Tihan T, et al. Impact of telemedicine
on pediatric neuro-oncology in a developing country:
the Jordanian–Canadian experience. Pediatr Blood
Cancer 2007;48(1):39–43.
14. Cancer Control. Knowledge into action. WHO
guide for Effective Programmes. Module 2:
Prevention. World Health Organization; 2007.
15. Abughosh S, Wu IH, Hawari F, Peters RJ, Yang
M, Crutchley R, et al. Cigarette smoking among
Jordanian adults. J Ethn Subst Abuse
2012;11(2):101–12.
16. Tobacco Free Initiative. Global youth tobacco
survey fact sheets and country reports, JordanHemato(2009). Geneva: World Health Organization; 2012
accessed July 01, 2014.
17. Muayyad Ahmad M, Al Gamal E, Othman A,
Nasrallah E. The National Survey. Knowledge,
attitudes and practices towards cancer prevention
and care in Jordan. Amman: King Hussein Institute
for Biotechnology and Cancer (KHIBC); 2014,
<http://www.academia.edu/6827170/Knowledge_
Attitudes_and_Practices_towards_Cancer_Prevention_
and_Care_in_Jordan> accessed Jan 15, 2015.
18. Global Bridges. <http://www.globalbridges.
org/> accessed 09 Jan 2014.
19. National Youth Strategy for Jordan (2005–
2009). The hashemite kingdom of Jordan higher
council for youth, UNDP, and Unicef. Amman; 2004
accessed July 01, 2014.
20. Breast Cancer Screening and Diagnosis
Guidelines. Amman: Jordan Breast Cancer
Program; 2008, <http://www.jbcp.jo/>.
21. Lynch T, Connor S, Clark D. Mapping levels of
palliative care development: a global update. J Pain
Symptom Manage 2013;45(6):1094–106.
22. Stjernswrd J, Ferris FD, Khleif SN, Jamous W,
Treish IM, Milhem M, et al. Jordan palliative care
initiative: a WHO Demonstration Project. J Pain
Symptom Manage 2007;33(5):628–33.l Oncol Stem Cell Ther 8(2) Second Quarter 2015
